ARCHIVES

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Simone Is AACI President-Elect; McGill, ICRC New Members; Engstrom ECOG Prevention Head

July 12, 1991

Coffey Presses NCI BSA chairman David Linvingston On support For Increase In NCI Budget

April 25, 1997

Sunitinib May Be Associated With Cardiac Toxicity

January 25, 2008

Draft Report Outlines New Toxicological Test Criteria

November 24, 1995

NCI Provides $40 Million To Four Centers For Cancer Communications Research.

June 27, 2003

O’Leary Leads RPCI’s OR;

February 8, 2002